FGFR1 and neoplasm: In this study, we successfully demonstrated the feasibility of sWGS (plasma-Seq) for detecting genome-wide structural genomic anomalies, including FGFR1 gene amplification, as well as estimating tumor content in the plasma of mBC patients.